Citalopram Provides Little or No Benefit in Nondepressed Patients With Irritable Bowel Syndrome

Citalopram was not superior to placebo in treating non-depressed IBS patients. Changes in symptoms were not substantially correlated with changes in rectal sensation assessed by barostat. Any benefit of citalopram in non-depressed IBS patients is likely to be modest at best.